Postinfectious irritable bowel syndrome may occur after non-gastrointestinal and intestinal infection

被引:35
作者
Mckeown, E. S. [1 ]
Parry, S. D. [1 ]
Stansfield, R. [1 ]
Barton, J. R. [1 ]
Welfare, M. R. [1 ]
机构
[1] Univ Newcastle, Fac Med, N Tyneside Gen Hosp, Northumbria Div, N Shields NE29 8NH, England
关键词
irritable bowel syndrome; postinfectious; functional gut disorder; prospective cohort study;
D O I
10.1111/j.1365-2982.2006.00821.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Postinfectious functional gastrointestinal disorders (FGIDs) may not be specific to gastroenteritis. This pilot study aimed to ascertain the 3- and 6-month incidence of functional gut disorders in people with non-gastrointestinal (GI) infection, gastroenteritis and healthy controls. This was a prospective study of three cohorts recruited from hospital (non-GI infections) and the community (others). FGIDs were diagnosed using self-completed Rome II modular questionnaires administered at baseline, 3 and 6 months. Thirty-six subjects with non-GI infection, 219 healthy subjects and 108 with bacterial gastroenteritis participated. No difference in incidence of FGID was detected between the GI and non-GI infection cohorts. Any FGID was more frequent in people who had a non-GI infection than in controls at both 3 [odds ratio: 4.34 (95% CI: 3.60-16.45)] and 6 months [4.76 (4.42-27.92)]. Irritable bowel syndrome (IBS) alone was more frequent in people with non-GI infections than in controls at 3 months (6.12 [1.30-29.12]) but did not quite reach statistical significance at 6 months (4.58 [0.79-26.46]). Our findings were unexpected. Postinfectious FGIDs may be related to non-GI and GI infection, although not all potential biases were controlled in study design. Further studies need to explore these preliminary findings and, if confirmed, the underlying mechanisms.
引用
收藏
页码:839 / 843
页数:5
相关论文
共 17 条
[1]
A role for inflammation in irritable bowel syndrome? [J].
Barbara, G ;
De Giorgio, R ;
Stanghellini, V ;
Cremon, C ;
Corinaldesi, R .
GUT, 2002, 51 :I41-I44
[2]
IRRITABLE-BOWEL-SYNDROME COULD BE AN INFLAMMATORY DISORDER [J].
COLLINS, SM .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1994, 6 (06) :478-482
[3]
DROSSMAN DA, 2000, ROME, V2
[4]
Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome [J].
Dunlop, SP ;
Jenkins, D ;
Neal, KR ;
Naesdal, J ;
Borgaonker, M ;
Collins, SM ;
Spiller, RC .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (01) :77-84
[5]
Do smoking parents seek the best advice for their asthmatic children? [J].
Friend, JAR .
THORAX, 2001, 56 (01) :1-1
[6]
Increased rectal mucosal expression of interleukin 1β in recently acquired post-infectious irritable bowel syndrome [J].
Gwee, KA ;
Collins, SM ;
Read, NW ;
Rajnakova, A ;
Deng, Y ;
Graham, JC ;
McKendrick, MW ;
Moochhala, SM .
GUT, 2003, 52 (04) :523-526
[7]
Psychometric scores and persistence of irritable bowel after infectious diarrhoea [J].
Gwee, KA ;
Graham, JC ;
McKendrick, MW ;
Collins, SM ;
Marshall, JS ;
Walters, SJ ;
Read, NW .
LANCET, 1996, 347 (8995) :150-153
[8]
The role of psychological and biological factors in postinfective gut dysfunction [J].
Gwee, KA ;
Leong, YL ;
Graham, C ;
McKendrick, MW ;
Collins, SM ;
Walters, SJ ;
Underwood, JE ;
Read, NW .
GUT, 1999, 44 (03) :400-406
[9]
Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study [J].
Halder, SLS ;
Locke, GR ;
Talley, NJ ;
Fett, SL ;
Zinsmeister, AR ;
Melton, LJ .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (02) :233-242
[10]
HIATT RB, 1962, AM J GASTROENTEROL, V37, P541